Drug Type Small molecule drug |
Synonyms 2,2-Dicarbamyloxymethyl-3-methylpentane, 2-Methyl-2-sec-butyl-1,3-propanediol dicarbamate, 2-sec-Butyl-2-methyl-1,3-propanediol dicarbamate + [8] |
Target |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date- |
Regulation- |
Molecular FormulaC10H20N2O4 |
InChIKeyLEROTMJVBFSIMP-UHFFFAOYSA-N |
CAS Registry64-55-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01807 | Mebutamate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | US | - |